Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: June 4, 2023

CEFAZOLIN SODIUM Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

When do Cefazolin Sodium patents expire, and what generic alternatives are available?

Cefazolin Sodium is a drug marketed by Abraxis Pharm, Acs Dobfar, Aurobindo Pharma, Bedford, Cephazone Pharma, Dr Reddys, Facta Farma, Fresenius Kabi Usa, Glaxosmithkline, Hikma, Hikma Farmaceutica, Hospira, Hospira Inc, Qilu, Samson Medcl, Sandoz, Steri Pharma, and Teva Pharms. and is included in thirty-three NDAs.

The generic ingredient in CEFAZOLIN SODIUM is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cefazolin Sodium

A generic version of CEFAZOLIN SODIUM was approved as cefazolin sodium by SANDOZ on December 9th, 1988.

  Try a Trial

Drug patent expirations by year for CEFAZOLIN SODIUM
Recent Clinical Trials for CEFAZOLIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

University of California, RiversidePhase 2/Phase 3
HK Surgical, Inc.Phase 2/Phase 3
University of British ColumbiaEarly Phase 1

See all CEFAZOLIN SODIUM clinical trials

Pharmacology for CEFAZOLIN SODIUM
Medical Subject Heading (MeSH) Categories for CEFAZOLIN SODIUM

US Patents and Regulatory Information for CEFAZOLIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 065047-002 Sep 18, 2001 AP RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Fresenius Kabi Usa CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 064170-002 Mar 18, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Qilu CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 203661-001 Dec 28, 2015 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.